SecBot SecBot
SECBOTREPLAY Home › Report › MNKD

MNKD · MannKind reported Q1 2026 GAAP EPS of -$0.05, a 600% miss vs

MannKind · PRESS-RELEASE filed May 6, 2026 at 16:01 ET

At the news

BEARISHIMPACT 8/10

PRESS-RELEASE filed May 6, 2026 at 16:01 ET

MannKind reported Q1 2026 GAAP EPS of -$0.05, a 600% miss vs. consensus of $0.01, and revenue of $90.2M, 14.4% below the $105.3M estimate. The miss was driven by a 116% surge in SG&A from Furoscix expansion and R&D ramp-up, despite a 15% YoY revenue increase. Pipeline catalysts (Afrezza pediatric PDUFA May 29, Furoscix ReadyFlow PDUFA July 26) provide optionality but do not offset the earnings disappointment.

  • GAAP EPS -$0.05 vs. consensus $0.01 (-600% miss)
  • Revenue $90.2M vs. consensus $105.3M (-14.4% miss)
  • YoY revenue growth 15% ($78.4M to $90.2M)
  • SG&A expenses increased 116% to $54.1M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access